We report a novel RPGR missense variant co-segregated with a familial X-linked retinitis pigmentosa (XLRP) case. The brothers were hemizygous for this variant, but only the proband presented with primary ciliary dyskinesia (PCD). Thus, we aimed to elucidate the role of the RPGR variant and other modifier genes in the phenotypic variability observed in the family and its impact on motile cilia. The pathogenicity of the variant on the RPGR protein was evaluated by in vitro studies transiently transfecting the mutated RPGR gene, and immunofluorescence analysis on nasal brushing samples. Whole-exome sequencing was conducted to identify potential modifier variants. In vitro studies showed that the mutated RPGR protein could not localise to the cilium and impaired cilium formation. Accordingly, RPGR was abnormally distributed in the siblings’ nasal brushing samples. In addition, a missense variant in CEP290 was identified. The concurrent RPGR variant influenced ciliary mislocalisation of the protein. We provide a comprehensive characterisation of motile cilia in this XLRP family, with only the proband presenting PCD symptoms. The variant’s pathogenicity was confirmed, although it alone does not explain the respiratory symptoms. Finally, the CEP290 gene may be a potential modifier for respiratory symptoms in patients with RPGR mutations.
Background: Previous studies found high but very variable levels of tetranor-PGEM and PGDM (urine metabolites of prostaglandin (PG) E2 and PGD2, respectively) in persons with cystic fibrosis (pwCF). This study aims to assess the role of cyclooxygenase COX-1 and COX-2 genetic polymorphisms in PG production and of PG metabolites as potential markers of symptoms’ severity and imaging findings. Methods: A total of 30 healthy subjects and 103 pwCF were included in this study. Clinical and radiological CF severity was evaluated using clinical scoring methods and chest computed tomography (CT), respectively. Urine metabolites were measured using liquid chromatography/tandem mass spectrometry. Variants in the COX-1 gene (PTGS1 639 C>A, PTGS1 762+14delA and COX-2 gene: PTGS2-899G>C (-765G>C) and PTGS2 (8473T>C) were also analyzed. Results: PGE-M and PGD-M urine concentrations were significantly higher in pwCF than in controls. There were also statistically significant differences between clinically mild and moderate disease and severe disease. Patients with bronchiectasis and/or air trapping had higher PGE-M levels than patients without these complications. The four polymorphisms did not associate with clinical severity, air trapping, bronchiectasis, or urinary PG levels. Conclusions: These results suggest that urinary PG level testing can be used as a biomarker of CF severity. COX genetic polymorphisms are not involved in the variability of PG production.
Background: Primary ciliary dyskinesia (PCD) is a disease characterized by an alteration in the ciliary structure that causes an abnormal clearance of respiratory secretions. Its diagnosis is complex and is based on a combination of different techniques. The objective of this study was to design a gene panel including all known caustive genes, and to verify the utility for diagnostic in a cohort of Spanish patients. Methods: Multicenter cross-sectional study of patients with high suspicion of PCD, applying the criteria of the European Respiratory Society. Design a gene panel for mass sequencing with SeqCap EZ technology, including 44 PCD-related genes. Results: 79 patients were included, 53 of those diagnosed with confirmed or highly likely PCD. The sensitivity of the gene panel was 81.1% with a specificity of 100%. Candidate variants were found in any of the panel genes 43 patients with PCD, with 51.2% (22/43) homozygous and 48.8% (21/43) compound heterozygous. The most common causal genes were DNAH5 and CCDC39, in patients of Caucasian origin, while in non-Caucasian ones the most common causal genes were CCDC40, DNAI2 and RSPH4A. We found 52 different variants, 36 not previously described in the literature. Conclusions: The results of this study show that the design and implementation of an specific gene panel has a high efficiency forgenetic diagnostic of PCD, allowing for a better understanding of the causal of this disease and laying the basis for future therapeutic approaches
Previous studies found high but very variable levels of tetranor-PGEM and PGD-M (urine metabolites of prostaglandin (PG) E2 and PGD2, respectively) in persons with cystic fibrosis (pwCF), which correlated with the severity of the CF transmembrane receptor (CFTR) genetic alteration. This study aims to assess the potential role of cyclooxygenase (COX)-1 and COX-2 genetic polymorphisms in the variability of PG production, and determine the potential role of PG metabolites as markers of symptoms severity and imaging findings. Thirty healthy subjects and 103 pwCF were included in the study. Clinical and radiological CF severity was evaluated using clinical scoring methods and the extent of bronchiectasis and air trapping were assessed by chest computed tomography (CT). Urine metabolites were measured using liquid chromatography/tandem mass spectrometry. The presence of variants in the COX-1 gen (PTGS1 639 C>A, PTGS1 762+14delA, and COX-2 gen: PTGS2-899G>C (-765G>C) and PTGS2 (8473T>C) were analysed. PGE-M and PGD-M urine concentrations were significantly higher in pwCF than in healthy controls. There were also statistically significant differences between clinically mild and moderate disease and severe disease. Patients with bronchiectasis and/or air trapping had higher PGE-M levels than patients without these complications. The four polymorphisms did not associate with clinical severity, air trapping, bronchiectasis, or urinary PG levels. Taken together, the present study suggests that urinary PG level testing can be used as a biomarker of CF severity. We found no relationship between COX-1 and COX-2 genetic polymorphisms in the variability of PG production.
Background: Primary ciliary dyskinesia (PCD) diagnosis is based on studying ciliary function by high-speed video-microscopy (HSVM) and ciliary ultrastructure by transmission electron microscopy (TEM). Immunofluorescence (IF) analysis has been proposed as a routine test to improve PCD diagnosis rate. We show a preliminary HSVM and IF results of PCD candidate patients Methods: A cohort of patients was studied because of high clinical suspicion of PCD. Samples of ciliated nasal epithelium were obtained by brushing. HSVM for analysing ciliary beat frequency (CBF, normal ≥9Hz) and pattern (CBP, normal ≤20% dyskinetic ciliated cells) was performed using a high-speed camera and optical microscope. Samples from 30 patients were prepared for IF analysis and labelled with a panel of 4 ciliary-ultrastructure antibodies: DNAH5, DNALI1, GAS8, RSPH4A Results: We present HSVM and IF results of 30 patients. HSVM analyses showed 22 (73%) patients presented a reduced CBF and 28 (93%) an altered CBP (12 had disorganised ciliary beat, 10 immotile cilia and 6 stiff cilia). Regarding IF analysis, 23 (77%) were evaluable for all antibodies: 14 were normal and 9 had one or moreabsent proteins (6 DNAH5, 1 DNALI1, 1 DNAH5 and DNALI1 and 1 DNAH5, DNALI1 and GAS8). All cases with a defect in IF presented a concordant CBP. Only one case with a normal IF had also a normal HSVM. The other 13 cases had a normal IF but an altered CBP, for which further studies are being performed Conclusion: The combination of HSVM and IF could explain an important number of cases, although other analyses will be necessary to increase the accuracy and diagnosis rate of PCD